Antifouling and antimicrobial biomaterials: an overview

APMIS

Volumn 125, Issue 4, 2017, Pages 392-417

  Francolini, Iolanda ^a   Vuotto, Claudia ^b   Piozzi, Antonella ^a   Donelli, Gianfranco ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

Author keywords

anti infective biomaterials; antifouling coatings; antimicrobial coatings; Medical devices; microbial biofilm

Indexed keywords

ANTIFOULING AGENT; ANTIINFECTIVE AGENT; BIOMATERIAL; CHLORHEXIDINE; FURANONE DERIVATIVE; MACROGOL; METAL OXIDE; NANOPARTICLE; NITRIC OXIDE; POLYMER; SILVER;

BIOFILM; HUMAN; MEDICAL DEVICE; MICROBIAL ADHESION; MICROBIAL GROWTH; NONHUMAN; PRIORITY JOURNAL; QUORUM SENSING; REVIEW; BACTERIUM; BACTERIUM ADHERENCE; CHEMISTRY; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; ISOLATION AND PURIFICATION; MICROBIOLOGY; PROSTHESES AND ORTHOSES; PROSTHESIS-RELATED INFECTIONS;

ANTI-INFECTIVE AGENTS; BACTERIA; BACTERIAL ADHESION; BIOCOMPATIBLE MATERIALS; BIOFILMS; HUMANS; PROSTHESES AND IMPLANTS; PROSTHESIS-RELATED INFECTIONS;

EID: 85017570645     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/apm.12675     Document Type: Review

References (257)

1. Ahmed S, Darouiche RO. Anti-biofilm agents in control of device-related infections. Adv Exp Med Biol 2015;831:137–46.
2. Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 2002;15:167–93.
3. Mah TF, O'Toole GA. Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol 2001;9:34–9.
4. Beloin C, Renard S, Ghigo JM, Lebeaux D. Novel approaches to combat bacterial biofilms. Curr Opin Pharmacol 2014;18:61–8.
5. Mihai MM, Holban AM, Giurcaneanu C, Popa LG, Oanea RM, Lazar V, et al. Microbial biofilms: impact on the pathogenesis of periodontitis, cystic fibrosis, chronic wounds and medical device-related infections. Curr Top Med Chem 2015;15:1552–76.
6. Percival SL, Suleman L, Vuotto C, Donelli G. Healthcare-associated infections, medical devices and biofilms: risk, tolerance and control. J Med Microbiol 2015;64:323–34.
7. Rosenthal VD, Maki DG, Graves N. The International Nosocomial Infection Control Consortium (INICC): goals and objectives, description of surveillance methods, and operational activities. Am J Infect Control 2008;36:e1–12.
8. Francolini I, Donelli G, Crisante F, Taresco V, Piozzi A. Antimicrobial polymers for anti-biofilm medical devices: state-of-art and perspectives. Adv Exp Med Biol 2015;831:93–117.
9. Thevenot P, Hu W, Tang L. Surface chemistry influences implant biocompatibility. Curr Top Med Chem 2008;8:270–80.
10. Pavithra D, Doble M. Biofilm formation, bacterial adhesion and host response on polymeric implants-issues and prevention. Biomed Mater 2008;3:034003.
11. Speziale P, Pietrocola G, Rindi S, Provenzano M, Provenza G, Di Poto A, et al. Structural and functional role of Staphylococcus aureus surface components recognizing adhesive matrix molecules of the host. Future Microbiol 2009;4:1337–52.
12. Hook AL, Chang CY, Yang J, Luckett J, Cockayne A, Atkinson S, et al. Combinatorial discovery of polymers resistant to bacterial attachment. Nat Biotechnol 2012;30:868–75.
13. Campoccia D, Montanaro L, Arciola CR. A review of the biomaterials technologies for infection-resistant surfaces. Biomaterials 2013;34:8533–54.
14. Francolini I, Donelli G. Prevention and control of biofilm-based medical-device-related infections. FEMS Immunol Med Microbiol 2010;59:227–38.
15. Donelli G, Francolini I, Piozzi A, Di Rosa R, Marconi W. New polymer-antibiotic systems to inhibit bacterial biofilm formation: a suitable approach to prevent central venous catheter-associated infections. J Chemother 2002;14:501–7.
16. Piozzi A, Francolini I, Occhiaperti L, Venditti M, Marconi W. Antimicrobial activity of polyurethanes coated with antibiotics: a new approach to the realization of medical devices exempt from microbial colonization. Int J Pharm 2004;280:173–83.
17. Francolini I, Norris P, Piozzi A, Donelli G, Stoodley P. Usnic acid, a natural antimicrobial agent able to inhibit bacterial biofilm formation on polymer surfaces. Antimicrob Agents Chemother 2004;48:4360–5.
18. Francolini I, D'Ilario L, Guaglianone E, Donelli G, Martinelli A, Piozzi A. Polyurethane anionomers containing metal ions with antimicrobial properties: thermal, mechanical and biological characterization. Acta Biomater 2010;6:3482–90.
19. Francolini I, Taresco V, Crisante F, Martinelli A, D'Ilario L, Piozzi A. Water soluble usnic acid-polyacrylamide complexes with enhanced antimicrobial activity against Staphylococcus epidermidis. Int J Mol Sci 2013;14:7356–69.
20. Woo GL, Yang ML, Yin HQ, Jaffer F, Mittelman MW, Santerre JP. Biological characterization of a novel biodegradable antimicrobial polymer synthesized with fluoroquinolones. J Biomed Mater Res 2002;59:35–45.
21. Kluin OS, van der Mei HC, Busscher HJ, Neut D. Biodegradable vs non-biodegradable antibiotic delivery devices in the treatment of osteomyelitis. Expert Opin Drug Deliv 2013;10:341–51.
22. Bertesteanu S, Chifiriuc MC, Grumezescu AM, Printza AG, Marie-Paule T, Grumezescu V, et al. Biomedical applications of synthetic, biodegradable polymers for the development of anti-infective strategies. Curr Med Chem 2014;21:3383–90.
23. Owens G, Singh R, Foroutan F, Alqaysi M, Han C-M, Mahapatra C, et al. Sol–gel based materials for biomedical applications. Prog Mater Sci 2016;77:1–79.
24. Hetrick EM, Schoenfisch MH. Reducing implant-related infections: active release strategies. Chem Soc Rev 2006;35:780–9.
25. Chang Y, Tai CL, Hsieh PH, Ueng SW. Gentamicin in bone cement: a potentially more effective prophylactic measure of infection in joint arthroplasty. Bone Joint Res 2013;2:220–6.
26. Chen AF, Parvizi J. Antibiotic-loaded bone cement and periprosthetic joint infection. J Long Term Eff Med Implants 2014;24:89–97.
27. Hinarejos P, Guirro P, Puig-Verdie L, Torres-Claramunt R, Leal-Blanquet J, Sanchez-Soler J, et al. Use of antibiotic-loaded cement in total knee arthroplasty. World J Orthop 2015;6:877–85.
28. Kendoff DO, Gehrke T, Stangenberg P, Frommelt L, Bosebeck H. Bioavailability of gentamicin and vancomycin released from an antibiotic containing bone cement in patients undergoing a septic one-stage total hip arthroplasty (THA) revision: a monocentric open clinical trial. Hip Int 2016;26:90–6.
29. Swearingen MC, Granger JF, Sullivan A, Stoodley P. Elution of antibiotics from poly(methyl methacrylate) bone cement after extended implantation does not necessarily clear the infection despite susceptibility of the clinical isolates. Pathog Dis 2016;74:ftv103.
30. Zhou Y, Li L, Zhou Q, Yuan S, Wu Y, Zhao H, et al. Lack of efficacy of prophylactic application of antibiotic-loaded bone cement for prevention of infection in primary total knee arthroplasty: results of a meta-analysis. Surg Infect 2015;16:183–7.
31. Norowski PA Jr, Bumgardner JD. Biomaterial and antibiotic strategies for peri-implantitis: a review. J Biomed Mater Res B Appl Biomater 2009;88:530–43.
32. Aviv M, Berdicevsky I, Zilberman M. Gentamicin-loaded bioresorbable films for prevention of bacterial infections associated with orthopedic implants. J Biomed Mater Res A 2007;83:10–9.
33. McLaren JS, White LJ, Cox HC, Ashraf W, Rahman CV, Blunn GW, et al. A biodegradable antibiotic-impregnated scaffold to prevent osteomyelitis in a contaminated in vivo bone defect model. Eur Cell Mater 2014;27:332–49.
34. Gollwitzer H, Ibrahim K, Meyer H, Mittelmeier W, Busch R, Stemberger A. Antibacterial poly(D, L-lactic acid) coating of medical implants using a biodegradable drug delivery technology. J Antimicrob Chemother 2003;51:585–91.
35. Vester H, Wildemann B, Schmidmaier G, Stockle U, Lucke M. Gentamycin delivered from a PDLLA coating of metallic implants: In vivo and in vitro characterisation for local prophylaxis of implant-related osteomyelitis. Injury 2010;41:1053–9.
36. Strobel C, Schmidmaier G, Wildemann B. Changing the release kinetics of gentamicin from poly(D, L-lactide) implant coatings using only one polymer. Int J Artif Organs 2011;34:304–16.
37. Radin S, Ducheyne P. Controlled release of vancomycin from thin sol-gel films on titanium alloy fracture plate material. Biomaterials 2007;28:1721–9.
38. Adams CS, Antoci V Jr, Harrison G, Patal P, Freeman TA, Shapiro IM, et al. Controlled release of vancomycin from thin sol-gel films on implant surfaces successfully controls osteomyelitis. J Orthop Res 2009;27:701–9.
39. Kalicke T, Schierholz J, Schlegel U, Frangen TM, Koller M, Printzen G, et al. Effect on infection resistance of a local antiseptic and antibiotic coating on osteosynthesis implants: an in vitro and in vivo study. J Orthop Res 2006;24:1622–40.
40. Back DA, Bormann N, Calafi A, Zech J, Garbe LA, Muller M, et al. Testing of antibiotic releasing implant coatings to fight bacteria in combat-associated osteomyelitis – an in-vitro study. Int Orthop 2016;40:1039–47.
41. Neut D, Dijkstra RJ, Thompson JI, Kavanagh C, van der Mei HC, Busscher HJ. A biodegradable gentamicin-hydroxyapatite-coating for infection prophylaxis in cementless hip prostheses. Eur Cell Mater 2015;29:42–55.
42. Sorensen JH, Lilja M, Sorensen TC, Astrand M, Procter P, Fuchs S, et al. Biomechanical and antibacterial properties of Tobramycin loaded hydroxyapatite coated fixation pins. J Biomed Mater Res B Appl Biomater 2014;102:1381–92.
43. Stigter M, Bezemer J, de Groot K, Layrolle P. Incorporation of different antibiotics into carbonated hydroxyapatite coatings on titanium implants, release and antibiotic efficacy. J Control Release 2004;99:127–37.
44. Radin S, El-Bassyouni G, Vresilovic EJ, Schepers E, Ducheyne P. In vivo tissue response to resorbable silica xerogels as controlled-release materials. Biomaterials 2005;26:1043–52.
45. Bumgardner JD, Wiser R, Gerard PD, Bergin P, Chestnutt B, Marin M, et al. Chitosan: potential use as a bioactive coating for orthopaedic and craniofacial/dental implants. J Biomater Sci Polym Ed 2003;14:423–38.
46. Davidoff SN, Sevy JO, Brooks BD, Grainger DW, Brooks AE. Evaluating antibiotic release profiles as a function of polymer coating formulation – biomed 2011. Biomed Sci Instrum 2011;47:46–51.
47. Cometa S, Mattioli-Belmonte M, Cafagna D, Iatta R, Ceci E, De Giglio E. Antibiotic-modified hydrogel coatings on titanium dental implants. J Biol Regul Homeost Agents 2012;26:65–71.
48. Darouiche RO, Raad II, Bodey GP, Musher DM. Antibiotic susceptibility of staphylococcal isolates from patients with vascular catheter-related bacteremia: potential role of the combination of minocycline and rifampin. Int J Antimicrob Agents 1995;6:31–6.
49. Drekonja DM, Kuskowski MA, Wilt TJ, Johnson JR. Antimicrobial urinary catheters: a systematic review. Expert Rev Med Devices 2008;5:495–506.
50. Leon C, Ruiz-Santana S, Rello J, de la Torre MV, Valles J, Alvarez-Lerma F, et al. Benefits of minocycline and rifampin-impregnated central venous catheters. A prospective, randomized, double-blind, controlled, multicenter trial. Intens Care Med 2004;30:1891–9.
51. Brun-Buisson C, Doyon F, Sollet JP, Cochard JF, Cohen Y, Nitenberg G. Prevention of intravascular catheter-related infection with newer chlorhexidine-silver sulfadiazine-coated catheters: a randomized controlled trial. Intens Care Med 2004;30:837–43.
52. Bonne S, Mazuski JE, Sona C, Schallom M, Boyle W, Buchman TG, et al. Effectiveness of minocycline and rifampin vs chlorhexidine and silver sulfadiazine-impregnated central venous catheters in preventing central line-associated bloodstream infection in a high-volume academic intensive care unit: a before and after trial. J Am Coll Surg 2015;221:739–47.
53. Gilbert RE, Mok Q, Dwan K, Harron K, Moitt T, Millar M, et al. Impregnated central venous catheters for prevention of bloodstream infection in children (the CATCH trial): a randomised controlled trial. Lancet 2016;387:1732–42.
54. Lai NM, Chaiyakunapruk N, Lai NA, O'Riordan E, Pau WS, Saint S. Catheter impregnation, coating or bonding for reducing central venous catheter-related infections in adults. Cochrane Database Syst Rev 2013;6:Art. No.: CD007878.
55. Halton KA, Cook DA, Whitby M, Paterson DL, Graves N. Cost effectiveness of antimicrobial catheters in the intensive care unit: addressing uncertainty in the decision. Crit Care 2009;13:R35.
56. Schierholz JM, Steinhauser H, Rump AF, Berkels R, Pulverer G. Controlled release of antibiotics from biomedical polyurethanes: morphological and structural features. Biomaterials 1997;18:839–44.
57. Piozzi A, Francolini I, Occhiaperti L, Di Rosa R, Ruggeri V, Donelli G. Polyurethanes loaded with antibiotics: influence of polymer-antibiotic interactions on in vitro activity against Staphylococcus epidermidis. J Chemother 2004;16:446–52.
58. Ruggeri V, Francolini I, Donelli G, Piozzi A. Synthesis, characterization, and in vitro activity of antibiotic releasing polyurethanes to prevent bacterial resistance. J Biomed Mater Res A 2007;81:287–98.
59. Crisante F, Francolini I, Bellusci M, Martinelli A, D'Ilario L, Piozzi A. Antibiotic delivery polyurethanes containing albumin and polyallylamine nanoparticles. Eur J Pharm Sci 2009;36:555–64.
60. Martinelli A, D'Ilario L, Francolini I, Piozzi A. Water state effect on drug release from an antibiotic loaded polyurethane matrix containing albumin nanoparticles. Int J Pharm 2011;407:197–206.
61. Milstone A, Passaretti C, Perl T. Chlorhexidine: expanding the armamentarium for infection control and prevention. Clin Infect Dis 2008;46:274–81.
62. Campbell AA, Song L, Li XS, Nelson BJ, Bottoni C, Brooks DE, et al. Development, characterization, and anti-microbial efficacy of hydroxyapatite-chlorhexidine coatings produced by surface-induced mineralization. J Biomed Mater Res 2000;53:400–7.
63. Cortizo MC, Oberti TG, Cortizo MS, Cortizo AM, Fernandez Lorenzo de Mele MA. Chlorhexidine delivery system from titanium/polybenzyl acrylate coating: evaluation of cytotoxicity and early bacterial adhesion. J Dent 2012;40:329–37.
64. James P, Parnell C, Whelton H. The caries-preventive effect of chlorhexidine varnish in children and adolescents: a systematic review. Caries Res 2010;44:333–40.
65. O'Keefe E. 10% chlorhexidine varnish did not reduce caries in an adult population. Evid Based Dent 2012;13:45.
66. Whitehouse M. Silver pharmacology: past, present and questions for the future. Prog Drug Res 2015;70:237–73.
67. Brett D. A discussion of silver as an antimicrobial agent: alleviating the confusion. Ostomy Wound Manag 2006;52:34–41.
68. Kim J, Kuk E, Yu K, Kim J, Park S, Lee H, et al. Antimicrobial effects of silver nanoparticles. Nanomed Nanotechnol Biol Med 2007;3:95–101.
69. Bragg P, Rainnie D. The effect of silver ions on the respiratory chain of Escherichia coli. Can J Microbiol 1974;20:883–9.
70. Zhang W, Luo Y, Wang H, Jiang J, Pu S, Chu P. Ag and Ag/N(2) plasma modification of polyethylene for the enhancement of antibacterial properties and cell growth/proliferation. Acta Biomater 2008;4:2028–36.
71. Kwok S, Zhang W, Wan G, McKenzie D, Bilek M, Chu P. Hemocompatibility and anti-bacterial properties of silver-doped diamond-like carbon prepared by pulsed filtered cathodic vacuum arc deposition. Diamond Relat Mater 2007;16:1353–60.
72. Ewald A, Gluckermann S, Thull R, Gbureck U. Antimicrobial titanium/silver PVD coatings on titanium. Biomed Eng Online 2006;5:22.
73. Chen W, Liu Y, Courtney H, Bettenga M, Agrawal C, Bumgardner J, et al. In vitro anti-bacterial and biological properties of magnetron co-sputtered silver-containing hydroxyapatite coating. Biomaterials 2006;27:5512–7.
74. Stickler D. Biomaterials to prevent nosocomial infections: is silver the gold standard? Curr Opin Infect Dis 2000;13:389–93.
75. Saint S, Elmore JG, Sullivan SD, Emerson SS, Koepsell TD. The efficacy of silver alloy-coated urinary catheters in preventing urinary tract infection: a meta-analysis. Am J Med 1998;105:236–41.
76. Davenport K, Keeley FX. Evidence for the use of silver-alloy-coated urethral catheters. J Hosp Infect 2005;60:298–303.
77. Schumm K, Lam TBL. Types of urethral catheters for management of short-term voiding problems in hospitalized adults: a short version Cochrane review. Neurourol Urodynam 2008;27:738–46.
78. Johnson JR, Johnston B, Kuskowski MA. In vitro comparison of nitrofurazone- and silver alloy-coated Foley catheters for contact-dependent and diffusible inhibition of urinary tract infection-associated microorganisms. Antimicrob Agents Chemother 2012;56:4969–72.
79. Pickard R, Lam T, Maclennan G, Starr K, Kilonzo M, McPherson G, et al. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short-term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial- and antiseptic-impregnated urethral catheters (the CATHETER trial). Health Technol Assess 2012;16:1–197.
80. Kalfon P, de Vaumas C, Samba D, Boulet E, Lefrant JY, Eyraud D, et al. Comparison of silver-impregnated with standard multi-lumen central venous catheters in critically ill patients. Crit Care Med 2007;35:1032–9.
81. Stoiser B, Kofler J, Staudinger T, Georgopoulos A, Lugauer S, Guggenbichler JP, et al. Contamination of central venous catheters in immunocompromised patients: a comparison between two different types of central venous catheters. J Hosp Infect 2002;50:202–6.
82. Corral L, Nolla-Salas M, Ibanez-Nolla J, Leon MA, Diaz RM, Cruz MM, et al. A prospective, randomized study in critically ill patients using the Oligon Vantex catheter. J Hosp Infect 2003;55:212–9.
83. Moretti EW, Ofstead CL, Kristy RM, Wetzler HP. Impact of central venous catheter type and methods on catheter-related colonization and bacteraemia. J Hosp Infect 2005;61:139–45.
84. Casey AL, Mermel LA, Nightingale P, Elliott TS. Antimicrobial central venous catheters in adults: a systematic review and meta-analysis. Lancet Infect Dis 2008;8:763–76.
85. Percival S, Woods E, Nutekpor M, Bowler P, Radford A, Cochrane C. Prevalence of silver resistance in bacteria isolated from diabetic foot ulcers and efficacy of silver-containing wound dressings. Ostomy Wound Manag 2008;54:30–40.
86. Kostenko V, Lyczak J, Turner K, Martinuzzi R. Impact of silver-containing wound dressings on bacterial biofilm viability and susceptibility to antibiotics during prolonged treatment. Antimicrob Agents Chemother 2010;54:5120–31.
87. Lok C-N, Ho C-M, Chen R, He Q-Y, Yu W-Y, Sun H. Proteomic analysis of the mode of antibacterial action of silver nanoparticles. J Proteome Res 2006;5:916–24.
88. Durán N, Durán M, de Jesus M, Seabra A, Fávaro W, Nakazato G. Silver nanoparticles: a new view on mechanistic aspects on antimicrobial activity. Nanomedicine 2016;12:789–99.
89. Anjum S, Gupta A, Sharma D, Gautam D, Bhan S, Sharma A, et al. Development of novel wound care systems based on nanosilver nanohydrogels of polymethacrylic acid with Aloe vera and curcumin. Mater Sci Eng C Mater Biol Appl 2016;64:157–66.
90. Wu K, Yang Y, Zhang Y, Deng J, Lin C. Antimicrobial activity and cytocompatibility of silver nanoparticles coated catheters via a biomimetic surface functionalization strategy. Int J Nanomed 2015;10:7241–52.
91. Stevens K, Croes S, Boersma R, Stobberingh E, van der Marel C, van der Veen F, et al. Hydrophilic surface coatings with embedded biocidal silver nanoparticles and sodium heparin for central venous catheters. Biomaterials 2011;32:1264–9.
92. Antonelli M, De Pasquale G, Ranieri V, Pelaia P, Tufano R, Piazza O, et al. Comparison of triple lumen central venous catheters impregnated with silver nanoparticles (AgTive) vs conventional catheters in intensive care unit patients. J Hosp Infect 2012;82:101–7.
93. de Nys R, Givskov M, Kumar N, Kjelleberg S, Steinberg PD. Furanones. Prog Mol Subcell Biol 2006;42:55–86.
94. Levy LM, Cabrera GM, Wright JE, Seldes AM. 5H-furan-2-ones from fungal cultures of Aporpium caryae. Phytochemistry 2003;62:239–43.
95. Janssens JC, De Keersmaecker SC, De Vos DE, Vanderleyden J. Small molecules for interference with cell-cell-communication systems in Gram-negative bacteria. Curr Med Chem 2008;15:2144–56.
96. Baveja JK, Li G, Nordon RE, Hume EB, Kumar N, Willcox MD, et al. Biological performance of a novel synthetic furanone-based antimicrobial. Biomaterials 2004;25:5013–21.
97. Baveja JK, Willcox MD, Hume EB, Kumar N, Odell R, Poole-Warren LA. Furanones as potential anti-bacterial coatings on biomaterials. Biomaterials 2004;25:5003–12.
98. Labib ME, Brumlik CJ, Stoodley P, Dukhin SS, Davidson T, Tabani Y. The long-term release of antibiotics from monolithic nonporous polymer implants for use as tympanostomy tubes. Colloids Surf A Physicochem Eng Asp 2010;254:331–7.
99. Yujie L, Geng X, Huang YC, Li Y, Yang K, Ye L, et al. The effect of brominated furanones on the formation of Staphylococcus aureus biofilm on PVC. Cell Biochem Biophys 2013;67:1501–5.
100. Lianhua Y, Yunchao H, Geng X, Youquang Z, Guangqiang Z, Yujie L. Effect of brominated furanones on the formation of biofilm by Escherichia coli on polyvinyl chloride materials. Cell Biochem Biophys 2013;67:893–7.
101. Martinelli A, Bakry A, D'Ilario L, Francolini I, Piozzi A, Taresco V. Release behavior and antibiofilm activity of usnic acid-loaded carboxylated poly(L-lactide) microparticles. Eur J Pharm Biopharm 2014;88:415–23.
102. Cheng Y, Wu J, Gao B, Zhao X, Yao J, Mei S, et al. Fabrication and in vitro release behavior of a novel antibacterial coating containing halogenated furanone-loaded poly(L-lactic acid) nanoparticles on microarc-oxidized titanium. Int J Nanomed 2012;7:5641–52.
103. Cheng Y, Zhao X, Liu X, Sun W, Ren H, Gao B, et al. Antibacterial activity and biological performance of a novel antibacterial coating containing a halogenated furanone compound loaded poly(L-lactic acid) nanoparticles on microarc-oxidized titanium. Int J Nanomed 2015;10:727–37.
104. Frost MC, Reynolds MM, Meyerhoff ME. Polymers incorporating nitric oxide releasing/generating substances for improved biocompatibility of blood-contacting medical devices. Biomaterials 2005;26:1685–93.
105. Arora DP, Hossain S, Xu Y, Boon EM. Nitric oxide regulation of bacterial biofilms. Biochemistry 2015;54:3717–28.
106. Nablo BJ, Prichard HL, Butler RD, Klitzman B, Schoenfisch MH. Inhibition of implant-associated infections via nitric oxide release. Biomaterials 2005;26:6984–90.
107. Holt J, Hertzberg B, Weinhold P, Storm W, Schoenfisch M, Dahners L. Decreasing bacterial colonization of external fixation pins through nitric oxide release coatings. J Orthop Trauma 2011;25:432–7.
108. Riccio DA, Coneski PN, Nichols SP, Broadnax AD, Schoenfisch MH. Photoinitiated nitric oxide-releasing tertiary S-nitrosothiol-modified xerogels. ACS Appl Mater Interfaces 2012;4:796–804.
109. Engelsman AF, Krom BP, Busscher HJ, van Dam GM, Ploeg RJ, van der Mei HC. Antimicrobial effects of an NO-releasing poly(ethylene vinylacetate) coating on soft-tissue implants in vitro and in a murine model. Acta Biomater 2009;5:1905–10.
110. Cai W, Wu J, Xi C, Meyerhoff ME. Diazeniumdiolate-doped poly(lactic-co-glycolic acid)-based nitric oxide releasing films as antibiofilm coatings. Biomaterials 2012;33:7933–44.
111. Munoz-Bonilla A, Fernandez-Garcýa M. Polymeric materials with antimicrobial activity. Prog Polym Sci 2012;37:281–339.
112. Siedenbiedel F, Tiller J. Antimicrobial polymers in solution and on surfaces: overview and functional principles. Polymer 2012;4:46–71.
113. Lawson MC, Shoemaker R, Hoth KB, Bowman CN, Anseth KS. Polymerizable vancomycin derivatives for bactericidal biomaterial surface modification: structure-function evaluation. Biomacromolecules 2009;10:2221–34.
114. Dizman B, Elasri MO, Mathias LJ. Synthesis, characterization, and antibacterial activities of novel methacrylate polymers containing norfloxacin. Biomacromolecules 2005;6:514–20.
115. Kenawy E, Mahmoud Y. Biologically active polymers. Macromol Biosci 2003;3:116.
116. Timofeeva L, Kleshcheva N. Antimicrobial polymers: mechanism of action, factors of activity, and applications. Appl Microbiol Biotechnol 2011;89:475–92.
117. Denyer S. Mechanisms of action of antibacterial biocides. Int Biodeterior Biodegrad 1995;36:227–45.
118. Masci G, Husu I, Murtas S, Piozzi A, Crescenzi V. Physical hydrogels of poly(vinyl alcohol) with different syndiotacticity prepared in the presence of lactosilated chitosan derivatives. Macromol Biosci 2003;3:455–61.
119. Kumar MN, Muzzarelli RA, Muzzarelli C, Sashiwa H, Domb AJ. Chitosan chemistry and pharmaceutical perspectives. Chem Rev 2004;104:6017–84.
120. Rabea EI, Badawy ME, Stevens CV, Smagghe G, Steurbaut W. Chitosan as antimicrobial agent: applications and mode of action. Biomacromolecules 2003;4:1457–65.
121. Liu X, Guan Y, Yang D, Li Z, Yao K. Antibacterial action of chitosan and carboxymethylated chitosan. J Appl Polym Sci 2001;79:1324–35.
122. Stepnova E, Tikhonov V, Babushkina T, Klimova T, Vorontsov E, Babak V, et al. New approach to the quaternization of chitosan and its amphiphilic derivatives. Eur Polym J 2007;43:2414–21.
123. Peng ZX, Tu B, Shen Y, Du L, Wang L, Guo SR, et al. Quaternized chitosan inhibits icaA transcription and biofilm formation by Staphylococcus on a titanium surface. Antimicrob Agents Chemother 2011;55:860–6.
124. Tan Y, Han F, Ma S, Yu W. Carboxymethyl chitosan prevents formation of broad-spectrum biofilm. Carbohydr Polym 2011;84:1365–70.
125. Wang R, Neoh KG, Shi Z, Kang ET, Tambyah PA, Chiong E. Inhibition of Escherichia coli and Proteus mirabilis adhesion and biofilm formation on medical grade silicone surface. Biotechnol Bioeng 2012;109:336–45.
126. Azzaroni O. Polymer brushes here, there, and everywhere: recent advances in their practical applications and emerging opportunities in multiple research fields. J Polym Sci Pol Chem 2012;50:3225–58.
127. Popelka A, Novak I, Lehocky M, Junkar I, Mozetic M, Kleinova A, et al. A new route for chitosan immobilization onto polyethylene surface. Carbohydr Polym 2012;90:1501–8.
128. Richert L, Lavalle P, Payan E, Shu XZ, Prestwich GD, Stoltz JF, et al. Layer by layer buildup of polysaccharide films: physical chemistry and cellular adhesion aspects. Langmuir 2004;20:448–58.
129. Bratskaya S, Marinin D, Simon F, Synytska A, Zschoche S, Busscher HJ, et al. Adhesion and viability of two enterococcal strains on covalently grafted chitosan and chitosan/kappa-carrageenan multilayers. Biomacromolecules 2007;8:2960–8.
130. Wang Y, Hong Q, Chen Y, Lian X, Xiong Y. Surface properties of polyurethanes modified by bioactive polysaccharide-based polyelectrolyte multilayers. Colloids Surf B Biointerfaces 2012;100:77–83.
131. Bulwan M, Wojcik K, Zapotoczny S, Nowakowska M. Chitosan-based ultrathin films as antifouling, anticoagulant and antibacterial protective coatings. J Biomater Sci Polym Ed 2012;23:1963–80.
132. Barros J, Dias A, Rodrigues M, Pina-Vaz C, Lopes M, Pina-Vaz I. Antibiofilm and antimicrobial activity of polyethylenimine: an interesting compound for endodontic treatment. J Contemp Dent Pract 2015;16:427–32.
133. Bergen JM, Park IK, Horner PJ, Pun SH. Nonviral approaches for neuronal delivery of nucleic acids. Pharm Res 2008;25:983–98.
134. Kim YH, Park JH, Lee M, Kim YH, Park TG, Kim SW. Polyethylenimine with acid-labile linkages as a biodegradable gene carrier. J Control Release 2005;103:209–19.
135. Lee Y, Mo H, Koo H, Park J, Cho M, Jin G, et al. Visualization of the degradation of a disulphide polymer, linear poly(ethyleneimine sulfide), for gene delivery. Bioconjug Chem 2006;18:13–8.
136. Liang B, He ML, Chan CY, Chen YC, Li XP, Li Y, et al. The use of folate-PEG-grafted-hybranched-PEI nonviral vector for the inhibition of glioma growth in the rat. Biomaterials 2009;30:4014–20.
137. Pasquier N, Keul H, Heine E, Moeller M, Angelov B, Linser S, et al. Amphiphilic branched polymers as antimicrobial agents. Macromol Biosci 2008;8:903–15.
138. Haldar J, Weight AK, Klibanov AM. Preparation, application and testing of permanent antibacterial and antiviral coatings. Nat Protoc 2007;2:2412–7.
139. Mukherjee K, Rivera JJ, Klibanov AM. Practical aspects of hydrophobic polycationic bactericidal “paints”. Appl Biochem Biotechnol 2008;151:61–70.
140. Park D, Wang J, Klibanov AM. One-step, painting-like coating procedures to make surfaces highly and permanently bactericidal. Biotechnol Prog 2006;22:584–9.
141. Hsu BB, Ouyang J, Wong SY, Hammond PT, Klibanov AM. On structural damage incurred by bacteria upon exposure to hydrophobic polycationic coatings. Biotechnol Lett 2011;33:411–6.
142. Schaer TP, Stewart S, Hsu BB, Klibanov AM. Hydrophobic polycationic coatings that inhibit biofilms and support bone healing during infection. Biomaterials 2012;33:1245–54.
143. Koplin SA, Lin S, Domanski T. Evaluation of the antimicrobial activity of cationic polyethylenimines on dry surfaces. Biotechnol Prog 2008;24:1160–5.
144. Milovic N, Wang J, Lewis K, Klibanov A. Immobilized N-alkylated polyethylenimine avidly kills bacteria by rupturing cell membranes with no resistance developed. Biotechnol Bioeng 2005;90:715–22.
145. Gultekinoglu M, Tunc SY, Erdogdu C, Sagiroglu M, Aksoy EA, Oh YJ, et al. Designing of dynamic polyethyleneimine (PEI) brushes on polyurethane (PU) ureteral stents to prevent infections. Acta Biomater 2015;21:44–54.
146. Atar-Froyman L, Sharon A, Weiss EI, Houri-Haddad Y, Kesler-Shvero D, Domb AJ, et al. Anti-biofilm properties of wound dressing incorporating nonrelease polycationic antimicrobials. Biomaterials 2015;46:141–8.
147. Francolini I, Piozzi A. Antimicrobial polyurethanes for intravascular medical devices. In: Cooper SL, Guan J, editors. Advances in Polyurethane Biomaterials. Duxford: Woodhead Publishing. 2016: 349–85.
148. Piozzi A, Francolini I. Biomimetic polyurethanes. In: Munoz-Bonilla A, Cerrada M, Fernandez-Garcia M, editors. Polymeric Materials with Antimicrobial Activity from Synthesis to Applications. Cambridge: RSC Publishing, 2014: 224–64.
149. Grapski JA, Cooper SL. Synthesis and characterization of non-leaching biocidal polyurethanes. Biomaterials 2001;22:2239–46.
150. Wynne J, Fulmer P, McCluskey D, Mackey N, Buchanan J. Synthesis and development of a multifunctional self-decontaminating polyurethane coating. ACS Appl Mater Interfaces 2011;3:2005–11.
151. Coneski PN, Fulmer PA, Wynne JH. Enhancing the fouling resistance of biocidal urethane coatings via surface chemistry modulation. Langmuir 2012;28:7039–48.
152. Bakhshi H, Yeganeh H, Mehdipour-Ataei S. Synthesis and evaluation of antibacterial polyurethane coatings made from soybean oil functionalized with dimethylphenylammonium iodide and hydroxyl groups. J Biomed Mater Res A 2013;101:1599–611.
153. Zanini S, Polissi A, Maccagni EA, Dell'Orto EA, Liberatore EC, Riccardi C. Development of antibacterial quaternary ammonium silane coatings on polyurethane catheters. J Colloid Interface Sci 2015;451:78–84.
154. Marconi W, Galloppa A, Martinelli A, Piozzi A. Novel polyurethane compositions able to bond high amounts of both albumin and heparin. 2. Copolymers and polymer blends. Biomaterials 1995;17:1795–802.
155. Gottenbos B, van der Mei HC, Klatter F, Nieuwenhuis P, Busscher HJ. In vitro and in vivo antimicrobial activity of covalently coupled quaternary ammonium silane coatings on silicone rubber. Biomaterials 2002;23:1417–23.
156. Oosterhof JJ, Buijssen KJ, Busscher HJ, van der Laan BF, van der Mei HC. Effects of quaternary ammonium silane coatings on mixed fungal and bacterial biofilms on tracheoesophageal shunt prostheses. Appl Environ Microbiol 2006;72:3673–7.
157. Majumdar P, Lee E, Gubbins N, Christianson DA, Stafslien SJ, Daniels J, et al. Combinatorial materials research applied to the development of new surface coatings XIII: an investigation of polysiloxane antimicrobial coatings containing tethered quaternary ammonium salt groups. J Comb Chem 2009;11:1115–27.
158. Ye S, Majumdar P, Chisholm B, Stafslien S, Chen Z. Antifouling and antimicrobial mechanism of tethered quaternary ammonium salts in a cross-linked poly(dimethylsiloxane) matrix studied using sum frequency generation vibrational spectroscopy. Langmuir 2010;26:16455–62.
159. Liu G, Wu D, Ma C, Zhang G, Wang H, Yang S. Insight into the origin of the thermosensitivity of poly[2-(dimethylamino)ethyl] methacrylate. Chem Phys Chem 2007;8:2254–9.
160. Chen Y, Wilbon P, Chen Y, Zhou J, Nagarkatti M, Wang C, et al. Amphipathic antibacterial agents using cationic methacrylic polymers with natural rosin as pendant group. RSC Adv 2012;2:10275–82.
161. Ganewatta MS, Miller KP, Singleton SP, Mehrpouya-Bahrami P, Chen YP, Yan Y, et al. Antibacterial and biofilm-disrupting coatings from resin acid-derived materials. Biomacromolecules 2015;16:3336–44.
162. Zhao J, Ma L, Millians W, Wu T, Ming W. Dual-functional antifogging/antimicrobial polymer coating. ACS Appl Mater Interfaces 2016;8:8737–42.
163. Farah S, Aviv O, Laout N, Ratner S, Beyth N, Domb AJ. Quaternary ammonium poly(diethylaminoethyl methacrylate) possessing antimicrobial activity. Colloids Surf B Biointerfaces 2015;128:608–13.
164. Kenawy E, Worley S, Broughton R. The chemistry and applications of antimicrobial polymers: a state-of-the-art review. Biomacromolecules 2007;8:1359–84.
165. Taresco V, Gontrani L, Crisante F, Francolini I, Martinelli A, D'Ilario L, et al. Self-assembly of catecholic moiety-containing cationic random acrylic copolymers. J Phys Chem B 2015;119:8369–79.
166. Siala W, Van Bambeke F, Taresco V, Piozzi A, Francolini I. Synergistic activity between an antimicrobial polyacrylamide and daptomycin vs. Staphylococcus aureus biofilm. Pathog Dis 2016;74(5):ftw042.
167. Taresco V, Francolini I, Padella F, Bellusci M, Boni A, Innocenti C, et al. Design and characterization of antimicrobial usnic acid loaded-core/shell magnetic nanoparticles. Mater Sci Eng C Mater Biol Appl 2015;52:72–81.
168. Taresco V, Crisante F, Francolini I, Martinelli A, D'Ilario L, Ricci-Vitiani L, et al. Antimicrobial and antioxidant amphiphilic random copolymers to address medical device-centered infections. Acta Biomater 2015;22:131–40.
169. Lin H, Liao S, Hung S. The DC thermal pasma synthesis of ZnO nanoparticles for visible-light photocatalyst. J Photochem Photobiol A: Chem 2005;174:82–7.
170. 2 photocatalytic disinfection. Water Res 2004;38:1069–77.
171. Li Y, Zhang W, Niu J, Chen Y. Mechanism of photogenerated reactive oxygen species and correlation with the antibacterial properties of engineered metal-oxide nanoparticles. ACS Nano 2012;6:5164–73.
172. Leyland NS, Podporska-Carroll J, Browne J, Hinder SJ, Quilty B, Pillai SC. Highly efficient F, Cu doped TiO2 anti-bacterial visible light active photocatalytic coatings to combat hospital-acquired infections. Sci Rep 2016;6:24770.
173. Evans P, Sheel D. Photoactive and antibacterial TiO2 thin films on stainless steel. Surf Coat Technol 2007;201:9319–24.
174. Yu JC, Ho W, Lin J, Yip H, Wong PK. Photocatalytic activity, antibacterial effect, and photoinduced hydrophilicity of TiO2 films coated on a stainless steel substrate. Environ Sci Technol 2003;37:2296–301.
175. Visai L, De Nardo L, Punta C, Melone L, Cigada A, Imbriani M, et al. Titanium oxide antibacterial surfaces in biomedical devices. Int J Artif Organs 2011;34:929–46.
176. Kulkarni M, Mazare A, Gongadze E, Perutkova S, Kralj-Iglic V, Milosev I, et al. Titanium nanostructures for biomedical applications. Nanotechnology 2015;26:062002.
177. von Wilmowsky C, Bauer S, Lutz R, Meisel M, Neukam FW, Toyoshima T, et al. In vivo evaluation of anodic TiO2 nanotubes: an experimental study in the pig. J Biomed Mater Res B Appl Biomater 2009;89:165–71.
178. Chun MJ, Shim E, Kho EH, Park KJ, Jung J, Kim JM, et al. Surface modification of orthodontic wires with photocatalytic titanium oxide for its antiadherent and antibacterial properties. Angle Orthod 2007;77:483–8.
179. Villatte G, Massard C, Descamps S, Sibaud Y, Forestier C, Awitor KO. Photoactive TiO(2) antibacterial coating on surgical external fixation pins for clinical application. Int J Nanomed 2015;10:3367–75.
180. Heidenau F, Mittelmeier W, Detsch R, Haenle M, Stenzel F, Ziegler G, et al. A novel antibacterial Titania coating: metal ion toxicity and in vitro surface colonization. J Mater Sci Mater Med 2005;16:883–8.
181. Haenle M, Fritsche A, Zietz C, Bader R, Heidenau F, Mittelmeier W, et al. An extended spectrum bactericidal titanium dioxide (TiO2) coating for metallic implants: in vitro effectiveness against MRSA and mechanical properties. J Mater Sci Mater Med 2011;22:381–7.
182. Mauerer A, Lange B, Welsch GH, Heidenau F, Adler W, Forst R, et al. Release of Cu2+ from a copper-filled TiO2 coating in a rabbit model for total knee arthroplasty. J Mater Sci Mater Med 2014;25:813–21.
183. Hang R, Gao A, Huang X, Wang X, Zhang X, Qin L, et al. Antibacterial activity and cytocompatibility of Cu-Ti-O nanotubes. J Biomed Mater Res A 2014;102:1850–8.
184. Yuan W, Ji J, Fu J, Shen J. A facile method to construct hybrid multilayered films as a strong and multifunctional antibacterial coating. J Biomed Mater Res B Appl Biomater 2008;85:556–63.
185. Li J, Liu X, Qiao Y, Zhu H, Ding C. Antimicrobial activity and cytocompatibility of Ag plasma-modified hierarchical TiO2 film on titanium surface. Colloids Surf B Biointerfaces 2014;113:134–45.
186. Zhang X, Wu H, Geng Z, Huang X, Hang R, Ma Y, et al. Microstructure and cytotoxicity evaluation of duplex-treated silver-containing antibacterial TiO(2) coatings. Mater Sci Eng C Mater Biol Appl 2014;45:402–10.
187. Gao A, Hang R, Huang X, Zhao L, Zhang X, Wang L, et al. The effects of Titania nanotubes with embedded silver oxide nanoparticles on bacteria and osteoblasts. Biomaterials 2014;35:4223–35.
188. Ohko Y, Utsumi Y, Niwa C, Tatsuma T, Kobayakawa K, Satoh Y, et al. Self-sterilizing and self-cleaning of silicone catheters coated with TiO(2) photocatalyst thin films: a preclinical work. J Biomed Mater Res 2001;58:97–101.
189. Wu JY, Li CW, Tsai CH, Chou CW, Chen DR, Wang GJ. Synthesis of antibacterial TiO2/PLGA composite biofilms. Nanomedicine 2014;10:1097–107.
190. Francolini I, Donelli G, Vuotto C, Baroncini FA, Stoodley P, Taresco V, et al. Antifouling polyurethanes to fight device-related staphylococcal infections: synthesis, characterization, and antibiofilm efficacy. Pathog Dis 2014;70:401–7.
191. Francolini I, Crisante F, Martinelli A, D'Ilario L, Piozzi A. Synthesis of biomimetic segmented polyurethanes as antifouling biomaterials. Acta Biomater 2012;8:549–58.
192. Schlenoff JB. Zwitteration: coating surfaces with zwitterionic functionality to reduce nonspecific adsorption. Langmuir 2014;30:9625–36.
193. Zhang H, Lamb R, Lewis J. Engineering nanoscale roughness on hydrophobic surface – preliminary assessment of fouling behaviour. Sci Technol Adv Mater 2005;6:236–9.
194. Chen SF, Li LY, Zhao C, Zheng J. Surface hydration: principles and applications toward low-fouling/nonfouling biomaterials. Polymer 2010;51:5283–93.
195. Jeon SI, Lee JH, Andrade JD, De Gennes PG. Protein-surface interactions in the presence of polyethylene oxide: I. Simplified theory. J Colloid Interf Sci 1991;142:149–58.
196. Roosjen A, van der Mei HC, Busscher HJ, Norde W. Microbial adhesion to poly(ethylene oxide) brushes: influence of polymer chain length and temperature. Langmuir 2004;20:10949–55.
197. Park KD, Kim YS, Han DK, Kim YH, Lee EH, Suh H, et al. Bacterial adhesion on PEG modified polyurethane surfaces. Biomaterials 1998;19:851–9.
198. Prime KL, Whitesides GM. Self-assembled organic monolayers: model systems for studying adsorption of proteins at surfaces. Science 1991;252:1164–7.
199. Prime KL, Whitesides GM. Adsorption of proteins onto surfaces containing end-attached oligo(ethylene oxide): a model system using self-assembled monolayers. J Am Chem Soc 1993;1993:10714–21.
200. Tegoulia V, Cooper S. Staphylococcus aureus adhesion to self assembled monolayers:effect of surface chemistry and fibrinogen presence. Colloids Surf B 2002;24:214–28.
201. Qian X, Metallo SJ, Choi IS, Wu H, Liang MN, Whitesides GM. Arrays of self-assembled monolayers for studying inhibition of bacterial adhesion. Anal Chem 2002;74:1805–10.
202. Corneillie S, Lan P, Schacht E, Davies M, Shard A, Green R, et al. Polyethylene glycol-containing polyurethanes for biomedical applications. Polym Int 1999;46:251–9.
203. Lee SW, Laibinis PE. Protein-resistant coatings for glass and metal oxide surfaces derived from oligo(ethylene glycol)-terminated alkytrichlorosilanes. Biomaterials 1998;19:1669–75.
204. Branch DW, Wheeler BC, Brewer GJ, Leckband DE. Long-term stability of grafted polyethylene glycol surfaces for use with microstamped substrates in neuronal cell culture. Biomaterials 2001;22:1035–47.
205. Ostuni E, Chapman R, Holmlin R, Takayama S, Whitesides G. A survey of structure-property relationships of surfaces that resist the adsorption of protein. Langmuir 2001;17:5605–20.
206. Roosjen A, de Vries J, van der Mei HC, Norde W, Busscher HJ. Stability and effectiveness against bacterial adhesion of poly(ethylene oxide) coatings in biological fluids. J Biomed Mater Res B Appl Biomater 2005;73:347–54.
207. Lewis A. Phosphorylcholine-based polymers and their use in the prevention of biofouling. Colloids Surf B 2000;18:261–75.
208. Hirota K, Murakami K, Nemoto K, Miyake Y. Coating of a surface with 2-methacryloyloxyethyl phosphorylcholine (MPC) co-polymer significantly reduces retention of human pathogenic microorganisms. FEMS Microbiol Lett 2005;248:37–45.
209. Cheng G, Zhang Z, Chen S, Bryers JD, Jiang S. Inhibition of bacterial adhesion and biofilm formation on zwitterionic surfaces. Biomaterials 2007;28:4192–9.
210. Cheng G, Li G, Xue H, Chen S, Bryers JD, Jiang S. Zwitterionic carboxybetaine polymer surfaces and their resistance to long-term biofilm formation. Biomaterials 2009;30:5234–40.
211. Zhang YL, Xia H, Kim E, Sun HB. Recent developments in superhydrophobic surfaces with unique structural and functional properties. Soft Matter 2012;8:11217–31.
212. Zhang XX, Wang L, Levanen E. Superhydrophobic surfaces for the reduction of bacterial adhesion. Rsc Advances 2013;3:12003–20.
213. Feng L, Li SH, Li YS, Li HJ, Zhang LJ, Zhai J, et al. Super-hydrophobic surfaces: from natural to artificial. Adv Mater 2002;14:1857–60.
214. Nishino T, Meguro M, Nakamae K, Matsushita M, Ueda Y. The lowest surface free energy based on -CF3 alignment. Langmuir 1999;15:4321–3.
215. Wenzel R. Resistance of solid surfaces to wetting by water. Ind Eng Chem 1936;28:988–94.
216. Cassie A, Baxter S. Wettability of porous surfaces. Trans Faraday Soc 1944;40:546–50.
217. Yang H, Deng Y. Preparation and physical properties of superhydrophobic papers. J Colloid Interf Sci 2008;325:588–93.
218. Okada A, Nikaido T, Ikeda M, Okada K, Yamauchi J, Foxton RM, et al. Inhibition of biofilm formation using newly developed coating materials with self-cleaning properties. Dent Mater J 2008;27:565–72.
219. Fadeeva E, Truong VK, Stiesch M, Chichkov BN, Crawford RJ, Wang J, et al. Bacterial retention on superhydrophobic titanium surfaces fabricated by femtosecond laser ablation. Langmuir 2011;27:3012–9.
220. Truong VK, Webb HK, Fadeeva E, Chichkov BN, Wu AHF, Lamb R, et al. Air-directed attachment of coccoid bacteria to the surface of superhydrophobic lotus-like titanium. Biofouling 2012;28:539–50.
221. Tang PF, Zhang W, Wang Y, Zhang BX, Wang H, Lin CJ, et al. Effect of superhydrophobic surface of titanium on Staphylococcus aureus adhesion. J Nanomater 2011;2011:doi:10.1155/2011/178921.
222. Privett BJ, Youn J, Hong SA, Lee J, Han J, Shin JH, et al. Antibacterial fluorinated silica colloid superhydrophobic surfaces. Langmuir 2011;27:9597–601.
223. Crick CR, Ismail S, Pratten J, Parkin IP. An investigation into bacterial attachment to an elastomeric superhydrophobic surface prepared via aerosol assisted deposition. Thin Solid Films 2011;519:3722–7.
224. Ivanova NA, Philipchenko AB. Superhydrophobic chitosan-based coatings for textile processing. Appl Surf Sci 2012;263:783–7.
225. Freschauf LR, McLane J, Sharma H, Khine M. Shrink-induced superhydrophobic and antibacterial surfaces in consumer plastics. PLoS One 2012;7:e40987.
226. Defoirdt T, Boon N, Bossier P. Can bacteria evolve resistance to quorum sensing disruption? PLoS Pathog 2010;6:e1000989.
227. Sifri CD. Healthcare epidemiology: quorum sensing: bacteria talk sense. Clin Infect Dis 2008;47:1070–6.
228. Schuster M, Sexton DJ, Diggle SP, Greenberg EP. Acyl-homoserine lactone quorum sensing: from evolution to application. Annu Rev Microbiol 2013;67:43–63.
229. Flavier AB, Clough SJ, Schell MA, Denny TP. Identification of 3-hydroxypalmitic acid methyl ester as a novel autoregulator controlling virulence in Ralstonia solanacearum. Mol Microbiol 1997;26:251–9.
230. Wang LH, Weng LX, Dong YH, Zhang LH. Specificity and enzyme kinetics of the quorum-quenching N-Acyl homoserine lactone lactonase (AHL-lactonase). J Biol Chem 2004;279:13645–51.
231. Cook LC, Federle MJ. Peptide pheromone signaling in Streptococcus and Enterococcus. FEMS Microbiol Rev 2014;38:473–92.
232. Fetzner S. Quorum quenching enzymes. J Biotechnol 2015;201:2–14.
233. Singh R, Desouky S, Nakayama J. Quorum quenching strategy targeting gram-positive pathogenic bacteria. Adv Exp Med Biol 2016;901:109–30.
234. Dong YH, Xu JL, Li XZ, Zhang LH. AiiA, an enzyme that inactivates the acylhomoserine lactone quorum-sensing signal and attenuates the virulence of Erwinia carotovora. Proc Natl Acad Sci USA 2000;97:3526–31.
235. Reimmann C, Ginet N, Michel L, Keel C, Michaux P, Krishnapillai V, et al. Genetically programmed autoinducer destruction reduces virulence gene expression and swarming motility in Pseudomonas aeruginosa PAO1. Microbiology 2002;148:923–32.
236. Vinoj G, Pati R, Sonawane A, Vaseeharan B. In vitro cytotoxic effects of gold nanoparticles coated with functional acyl homoserine lactone lactonase protein from Bacillus licheniformis and their antibiofilm activity against Proteus species. Antimicrob Agents Chemother 2015;59:763–71.
237. Leadbetter JR, Greenberg EP. Metabolism of acyl-homoserine lactone quorum-sensing signals by Variovorax paradoxus. J Bacteriol 2000;182:6921–6.
238. Huang JJ, Han JI, Zhang LH, Leadbetter JR. Utilization of acyl-homoserine lactone quorum signals for growth by a soil pseudomonad and Pseudomonas aeruginosa PAO1. Appl Environ Microbiol 2003;69:5941–9.
239. Wahjudi M, Papaioannou E, Hendrawati O, van Assen AH, van Merkerk R, Cool RH, et al. PA0305 of Pseudomonas aeruginosa is a quorum quenching acylhomoserine lactone acylase belonging to the Ntn hydrolase superfamily. Microbiology 2011;157:2042–55.
240. Paul D, Kim Y, Ponnusamy K, Kweon JH. Application of quorum quenching to inhibit biofilm formation. Environmental Eng Sci 2009;26:1319–26.
241. Kim M, Lee S, Park HD, Choi SI, Hong S. Biofouling control by quorum sensing inhibition and its dependence on membrane surface. Water Sci Technol 2012;66:1424–30.
242. Kisch JM, Utpatel C, Hilterhaus L, Streit WR, Liese A. Pseudomonas aeruginosa biofilm growth inhibition on medical plastic materials by immobilized esterases and acylase. ChemBioChem 2014;15:1911–9.
243. Ivanova K, Fernandes MM, Mendoza E, Tzanov T. Enzyme multilayer coatings inhibit Pseudomonas aeruginosa biofilm formation on urinary catheters. Appl Microbiol Biotechnol 2015;99:4373–85.
244. Ivanova K, Fernandes MM, Francesko A, Mendoza E, Guezguez J, Burnet M, et al. Quorum-quenching and matrix-degrading enzymes in multilayer coatings synergistically prevent bacterial biofilm formation on urinary catheters. ACS Appl Mater Interfaces 2015;7:27066–77.
245. Grover N, Plaks JG, Summers SR, Chado GR, Schurr MJ, Kaar JL. Acylase-containing polyurethane coatings with anti-biofilm activity. Biotechnol Bioeng 2016;113:2535–43.
246. Flemming H-C, Wingender J. The biofilm matrix. Nat Rev Microbiol 2010;8:623–33.
247. Kaplan JB, Ragunath C, Ramasubbu N, Fine DH. Detachment of Actinobacillus actinomycetemcomitans biofilm cells by an endogenous beta-hexosaminidase activity. J Bacteriol 2003;185:4693–8.
248. Kaplan JB, Meyenhofer MF, Fine DH. Biofilm growth and detachment of Actinobacillus actinomycetemcomitans. J Bacteriol 2003;185:1399–404.
249. Itoh Y, Wang X, Hinnebusch BJ, Preston JF 3rd, Romeo T. Depolymerization of beta-1,6-N-acetyl-D-glucosamine disrupts the integrity of diverse bacterial biofilms. J Bacteriol 2005;187:382–7.
250. Izano EA, Wang H, Ragunath C, Ramasubbu N, Kaplan JB. Detachment and killing of Aggregatibacter actinomycetemcomitans biofilms by dispersin B and SDS. J Dent Res 2007;86:618–22.
251. Donelli G, Francolini I, Romoli D, Guaglianone E, Piozzi A, Ragunath C, et al. Synergistic activity of dispersin B and cefamandole nafate in inhibition of staphylococcal biofilm growth on polyurethanes. Antimicrob Agents Chemother 2007;51:2733–40.
252. Pavlukhina SV, Kaplan JB, Xu L, Chang W, Yu X, Madhyastha S, et al. Noneluting enzymatic antibiofilm coatings. ACS Appl Mater Interfaces 2012;4:4708–16.
253. Gawande PV, Leung KP, Madhyastha S. Antibiofilm and antimicrobial efficacy of DispersinB(R)-KSL-W peptide-based wound gel against chronic wound infection associated bacteria. Curr Microbiol 2014; 68:635–41.
254. Tetz GV, Artemenko NK, Tetz VV. Effect of DNase and antibiotics on biofilm characteristics. Antimicrob Agents Chemother 2009;53:1204–9.
255. Baelo A, Levato R, Julian E, Crespo A, Astola J, Gavalda J, et al. Disassembling bacterial extracellular matrix with DNase-coated nanoparticles to enhance antibiotic delivery in biofilm infections. J Control Release 2015;209:150–8.
256. Swartjes J, Das T, Sharifi S, Subbiahdoss G, Sharma P, Krom B, et al. A functional DNase I coating to prevent adhesion of bacteria and the formation of biofilm. Adv Funct Mater 2013;23:2843–9.
257. Ghanwate N, Thakare P, Bhise PR, Tayde S. Prevention of biofilm formation in urinary catheters by treatment with antibiofilm agents. Int J Sci Res 2014;3:714–7.